Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

Citations Over TimeTop 10% of 2011 papers

Abstract

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not significantly affect posttransplant survival. The MELD score can be used to optimize the allocation of allografts according to a sickest first policy. Most often, patients with small hepatocellular carcinomas (HCCs) and low MELD scores receive extra points, which allow them appropriate access to transplantation comparable to the access of patients with advanced cirrhosis and high MELD scores. In addition to patients with advanced cirrhosis and HCC, patients with a number of relatively uncommon conditions have low MELD scores and a poor prognosis in the short term without transplantation but derive excellent benefits from transplantation. These conditions, which correspond to the so-called MELD score exceptions, justify the allocation of a specific score for appropriate access to transplantation. Here we report the conclusions of the French consensus meeting. The goals of this meeting were (1) to identify which conditions merit MELD score exceptions, (2) to list the criteria needed for defining each of these conditions, and (3) to define a reasonable time interval for organ allocation for each MELD exception in the general context of organ shortages. MELD exceptions were discussed in an attempt to reconcile the concepts of transparency, equity, justice, and utility.

Related Papers

• → Model for end-stage liver disease (MELD) and allocation of donor livers(2003)2,508 cited
• → Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis?(2005)419 cited
• → Important predictor of mortality in patients with end-stage liver disease(2013)133 cited
• → Is severe progressive liver disease caused by alpha‐1‐antitrypsin deficiency more common in children or adults?(2016)45 cited
• → A Comparison of Child-Turcotte-Pugh Classification with Four Models of End-Stage Liver Disease-Based Prognostic System for Spontaneous Bacterial Peritionitis in Cirrhosis(2011)